Aging-related secretory proteins have great potential as robust and diverse biomarkers of aging, and the study of protein biomarkers is beneficial for aging evaluation and the prevention and treatment of aging-related diseases. For the hot research of aging biomarkers, CD BioSciences provides multiple discovery strategies and platform services to identify aging-related protein biomarkers from biological samples such as tissues and cells.
We can identify protein biomarkers of aging through different putative strategies, which can serve as indicators of the aging process and potential targets for interventions.
Comparative proteome
We compare protein expression profiles between young and old individuals or between different age groups, to identify proteins that significantly change in abundance with age. Then, we use techniques such as mass spectrometry-based proteomics, including label-based or label-free quantification methods for quantitative analysis of proteomic biomarkers.
Recombinant antibody technology
We develop methods based on recombinant antibody technology to identify biomarkers on cells in heterogeneous populations and then test for compliance with aging biomarkers.
We use innovative and robust high-throughput proteomics technologies to discover biomarkers of aging from in vitro studies or animal models. These protein biomarkers can be used to assess individuals or to identify specific age-related diseases.
Next-generation sequencing services
Sample proteins are enzymatically digested, chromatographically separated, and injected into the mass spectrometer, using a tandem mass spectrometer to detect quantitative differences and minimize bias.
Protein microarrays services
Arrays covering a wide range of aging proteomes, screen your samples for specific proteins at the proteomic level by using large libraries of diverse antibodies, and then test them to see if they meet aging markers.
Comparison of biological samples. Compare biological samples, including serum, cells, tissues, etc. from older or younger groups, and healthy or diseased groups.
Get big data from small samples. Obtain large amounts of high-quality sample-specific, reliable, and reproducible data from samples of only a few tens of microliters.
Assumption-free and unbiased analysis. Our assays are not based on preconceived assumptions or selections and are checked and validated by multiple strategies and platforms to help you identify target proteins.
Professional team support. An experienced team of experts assists in problem-solving throughout the process, jointly preparing and executing experimental protocols to ensure professional data results.
Based on a proteomics approach, CD BioSciences provides discovery services for protein biomarkers of aging to aid in the development of age prediction models and interventions for aging, or to diagnose specific age-related diseases. If you are interested in our services, please feel free to contact us or make an online inquiry.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
CD BioScience is a research service provider focused on aging research, specializing in providing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products.
Copyright © 2024 CD BioSciences. All rights reserved.